Remove 2019 Remove Governance Remove Licensing Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

A new template for the Certificate of a Pharmaceutical Product will be put into use in line with China’s pharmaceutical export practices and the latest World Health Organization (WHO) guidelines. China’s drug MAH system has been implemented nationwide since the revised Drug Administration Law came into force in 2019.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

Time frame for Accepting CE Marked Medical Devices in Great Britain Extended, 01 July 2023 The United Kingdom (UK) government has made regulations ( The Medical Devices (Amendment) (Great Britain) Regulations 2023 ) that enable CE marked medical devices to be accepted in Great Britain for defined periods beyond 30 June 2023.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

This guidance does not intend to elaborate on aspects related to the clinical evaluation or cybersecurity for these products, as those are described in other guidelines ( MDCG 2020-1 on Clinical Evaluation (MDR) / Performance Evaluation (IVDR) of Medical Device Software; MDCG 2019-16 on Cybersecurity for medical devices).

FDA 52